Tuberculosis

European Respiratory Monograph

Volumn 5, Issue 15, 2000, Pages 67-91

  Enarson, D A ^a   Ait Khaled, N ^a  

^a INTERNATIONAL UNION AGAINST TUBERCULOSIS AND LUNG DISEASE   (France)

Author keywords

Bacteriology; Exposure; Immunity; Infection; Tuberculosis

Indexed keywords

ISONIAZID; RIFAMPICIN; STREPTOMYCIN; TUBERCULOSTATIC AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; DISEASE COURSE; DISEASE MODEL; HUMAN; IMMUNITY; INFECTION SENSITIVITY; PATHOGENESIS; PROBABILITY; REVIEW; RISK FACTOR; SOCIAL ASPECT; TREATMENT FAILURE; TREATMENT PLANNING; TUBERCULOSIS;

EID: 0033779405     PISSN: 1025448X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (135)

1. Epidemiology of tuberculosis
2. Epidemiology of tuberculosis in Europe
3. Tuberculosis
4. Global tuberculosis incidence and mortality during 1990-2000
5. Secular trends of tuberculosis in Western Europe
6. Tuberculosis-a bridge to chronic disease epidemiology
7. Der Verlauf der Tuberculose durch Generationen
8. Tuberculosis in hospital nurses
9. The age selection of mortality from tuberculosis in successive decades
10. Relation of economic status to tuberculosis mortality by age and sex
11. Epidemiological basis of tuberculosis eradication. 2. Dynamics of tuberculosis morbidity and mortality
12. The challenge of tuberculosis in decline
13. Transmission of tubercle bacilli: The effects of chemotherapy
14. Epidemiology of tuberculosis
15. The epidemiological situation of tuberculosis and the impact of control measures
16. Research towards global control and prevention of tuberculosis with an emphasis on vaccine development
17. Epidemiology of tuberculosis in the United States
18. Herd immunity: History, theory and practice
19. The use of an epidemiological model for estimating the effectiveness of tuberculosis control measures. Sensitivity of the effectiveness of tuberculosis control measures to the coverage of the population
20. The epidemiological basis of tuberculosis control
21. A Dictionary of Epidemiology
22. Opportunity for exposure and risk of infection: The fuel for the tuberculosis pandemic
23. Infectivity of pulmonary tuberculosis in relation to sputum status
24. Contacts of cases of active pulmonary tuberculosis
25. Tuberculosis in BCG vaccinated and non vaccinated young adults
26. Tuberculosis in young adults
27. The time table of tuberculosis
28. Tuberculosis morbidity in a controlled trial of the prophylactic use of isoniazid among household contacts
29. Final report of the Medical Research Council by its Tuberculosis Vaccines Clinical Trials Committee. BCG and vole bacillus vaccines in the prevention of tuberculosis in adolescence and early adult life
30. Chest radiographic studies in patients with tuberculosis with recent or remote infection
31. A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection
32. Ten-year results during the introduction of chemotherapy for tuberculosis
33. The ultimate results in 1,694 cases of tuberculosis treated at the Modern Woodmen of America Sanatorium
34. National Tuberculosis Institute Tuberculosis in a rural population of South India A five-year epidemiological study
35. Miliary tuberculosis in British Columbia
36. Follow-up of 1,041 tuberculous patients
37. Deaths in tuberculosis patients in British Columbia, 1980-1984
38. Impact of human immunodeficiency virus infection on the outcome of treatment and survival of tuberculosis patients in Mwanza, Tanzania
39. Epidemiology of tuberculosis and the role of BCG
40. Lifelong follow-up of inactive tuberculosis: Its value and limitations
41. The IUAT trial on isoniazid preventive treatment in persons with fibrotic lung lesions
42. Transmission of tuberculosis in New York City: An analysis by DNA fingerprinting and conventional epidemiologic methods
43. Unexpectedly high strain diversity of Mycobacterium tuberculosis in a high-incidence community
44. The epidemiology of tuberculosis in San Francisco: A population based study using conventional and molecular methods
45. The arcana of tuberculosis: With a brief epidemiologic history of the disease in USA
46. The fate of cases of pulmonary tuberculosis under various treatment programmes
47. Deaths from pulmonary tuberculosis in a low-incidence country
48. Public Health Mycobacteriology: A guide for the Level III Laboratory
49. Molecular strain typing of Mycobacterium tuberculosis to confirm cross-contamination in the mycobacteriology laboratory and modification of procedures to minimize occurrence of false-positive cultures
50. Investigation of cross contamination in a Mycobacterium tuberculosis laboratory using IS6110 DNA fingerprinting
51. The yield of acid-fast bacilli from serial smears in routine microscopy laboratories in rural Tanzania
52. Bacteriology of mycobacterioses
53. Incidence and natural history of Mycobacterium avium-complex infections in patients with acquired immunodeficiency virus disease treated with zidovudine
54. Bacteriological methods for the detection of cases of pulmonary tuberculosis
55. Epidemiological and clinical study of tuberculosis in the district of Kolin, Czechoslovakia. Report for the first 4 years of the study (1961-1964)
56. Detection of tuberculosis, past, present and future
57. Molecular epidemiology of tuberculosis
58. Aspects of tuberculosis in Africa. 3. Genetic fingerprinting for clues to the pathogenesis of tuberculosis
59. Exogenous reinfection with mutidrug resistant M. tuberculosis in patients with advanced HIV infection
60. Application of DNA fingerprinting with IS986 to sequential mycobacterial isolates obtained from pulmonary tuberculosis patients in Hong Kong before, during and after short-course chemotherapy
61. The role of dual reading in mass radiography
62. Descriptive classification of pulmonary shadows: A revelation of unreliability in the roentgenographic diagnosis of tuberculosis
63. Results of the study on X-ray readings of the ad hoc Committee for the Study of Classification and Terminology in Tuberculosis
64. Description of the study material and organization of the study
65. Results of the international study on X-ray classification
66. Committee on Diagnostic Standards
67. Presumptive diagnosis and treatment of pulmonary tuberculosis based on radiographic findings
68. Methods of diagnosing tuberculosis among in-patients in Eastern Africa whose sputum smears are negative
69. Notification of tuberculosis: How many cases are never reported?
70. Estimated global incidence of smear-positive pulmonary tuberculosis. Unreliability of officially reported figures on tuberculosis
71. Methodological issues in the estimation of the tuberculosis problem from tuberculin surveys
72. A method of estimating the prevalence of tuberculous infection
73. Tuberculosis morbidity in the US Navy: Its distribution and decline
74. Efficacy of BCG vaccine against leprosy and tuberculosis in northern Malawi
75. Tuberculosis in Aboriginals in Canada
76. Bacille Calmette-Guerin vaccinations and tuberculin skin tests
77. Tuberculosis in eskimos
78. Bacteriological and X-ray status of tuberculosis following primary infection acquired during adolescence or later
79. Tuberculosis mortality and morbidity and tuberculin sensitivity in Norway
80. La morbidit-tuberculeuse de 1982 a 1990 en Algerie
81. Incidence of active tuberculosis in the native population of Canada
82. The unchanging pattern of pulmonary tuberculosis
83. Recent advances in epidemiological research in tuberculosis
84. The incidence of active tuberculosis in a large urban area
85. Evaluation of a standardized recording tool for sputum smear microscopy for acid-fast bacilli under routine conditions in low income countries
86. Tuberculosis in tropical Africa
87. Tuberculosis in Indian children
88. Incidence of tuberculosis among Scandinavian immigrants in Canada
89. Non-respiratory tuberculosis in Canada: Epidemiologic and bacteriologic features
90. Tuberculosis risk and marital status
91. Evaluation of the Tuberculosis Problem and Control Measures in Canada
92. Inner-city survey for tuberculosis: Evaluation of diagnostic methods
93. Height, weight and mortality, the Norwegian experience
94. Airway size and the rate of pulmonary function decline in grainhandlers
95. Tuberculosis and HIV infection in sub Saharan Africa
96. Haemophilia and tuberculosis
97. Peptic ulcer, partial gastrectomy, and pulmonary tuberculosis
98. II. Incidence of pulmonary tuberculosis among diabetics
99. Silicosis and risk of lung cancer or lung tuberculosis: A cohort study
100. Epidemiological basis of tuberculosis eradication. 4. Longitudinal studies on the risk of tuberculosis in the general population of a low-prevalence area
101. Four population groups with relatively high tuberculosis incidence in Goteborg 1957-1964
102. The prognosis of a positive tuberculin reaction in childhood and adolescence
103. Pneumonie et tuberculose chez les troupes noires
104. Tuberculosis in primitive tribes and its bearing on tuberculosis of civilized communities
105. Tuberculosis in immigrants to Canada: A study of present day patterns in relation to immigration trends and birthplace
106. A decade of experience with Mycobacterium tuberculosis culture from children: A seasonal influence on incidence of childhood tuberculosis
107. Epidemiologie und Statisik der Tuberkulose
108. The effect of war on tuberculosis
109. An estimate of the future size of the tuberculosis problem in sub-Saharan Africa resulting from HIV infection
110. Tuberculosis trends in eastern Europe and the former USSR
111. The contribution of medical measures to the decline of mortality from respiratory tuberculosis: An age-period-cohort model
112. Air hygiene in tuberculosis: Quantitative studies of infectivity and control in a pilot ward
113. Focusing tuberculosis contact tracing by smear grading of index cases
114. Studies on factors influencing patients', doctors' delay of tuberculosis case detection in Japan
115. Impact of human immunodeficiency virus infection on the epidemiology, clinical features, management and control of tuberculosis
116. The early bactericidal activity of drugs in patients with pulmonary tuberculosis
117. Sputum smear conversion during directly observed treatment for tuberculosis
118. Misbehaviour of a dying epidemic: A call for less speculation and better surveillance
119. Tuberculosis guide for low income countries, 4th edn
120. A controlled trial of six months chemotherapy in pulmonary tuberculosis. First report: Results during chemotherapy
121. Changes in tuberculosis prevalence in a south Indian rural community following a tuberculosis control programme over a seven years' period
122. The contribution of treatment to the prevention of tuberculosis
123. Analysis of chronic excretors of Mycobacterium tuberculosis in Aichi Prefecture
124. The 5-year outcome of multidrug resistant tuberculosis patients in Cape Province of South Africa
125. Drug resistance and tuberculosis elimination
126. Why not the elimination of tuberculosis?
127. Tuberculosis elimination in the countries of Europe and other industrialized countries
128. The U-shaped curve of concern